A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionEfficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusEfficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B VirusSafety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB InfectionSafety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 TrialsSafety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV18F-FMAU PET/CT in Imaging Patients With Advanced CancersThe Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19
P4844
Q61914858-F82BB770-A55A-464F-B5AD-48EBF41EB0ABQ61917509-7CACD78D-CF28-4C69-8E82-56F41972532CQ61917524-FB666FFD-8232-498D-9896-A005317CC1F7Q61934800-F6F41BCE-32A1-49FD-81D9-AC3AA061ED51Q61934817-8AD1F36B-DCEF-4C03-97CD-647B63B8084FQ61934853-B13FC612-0787-479F-A324-DFCB6620AB73Q61980364-73D0B34A-6C08-4C59-8F62-C41DF96E0DC6Q63590769-A71BB271-08F6-45AC-A1E0-03F819CC5396Q93704667-8B924789-F2D2-4A44-AF4B-A74C00849568
P4844
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Clevudin
@de
Clevudine
@vi
Klevudin
@sh
Klevudin
@sr
clevudine
@en
type
label
Clevudin
@de
Clevudine
@vi
Klevudin
@sh
Klevudin
@sr
clevudine
@en
altLabel
Clevudine
@en
L-FMAU
@en
prefLabel
Clevudin
@de
Clevudine
@vi
Klevudin
@sh
Klevudin
@sr
clevudine
@en
P486
P592
P6366
P661
P662
P665
P683
P2017
CC1=CN(C(=O)NC1=O)[C@@H]2[C@@H]([C@H]([C@@H](O2)CO)O)F
P2067
P2175
P231
163252-36-6
P233
CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F
P234
1S/C10H13FN2O5/c1-4-2-13(10(17 ...... H,12,16,17)/t5-,6+,7-,9-/m0/s1
P235
GBBJCSTXCAQSSJ-XQXXSGGOSA-N
P267
P274
C₁₀H₁₃FN₂O₅
P2868
P3117
DTXSID2057659